Knoll Capital Management
Latest statistics and disclosures from Knoll Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ALDX, Biohaven Pharmaceutical Holding, NUVB, Flamel Technologies Sa, GLD, and represent 42.98% of Knoll Capital Management's stock portfolio.
- Added to shares of these 5 stocks: Biohaven Pharmaceutical Holding (+$16M), RGLD (+$9.7M), SSRM (+$5.4M), NUVB, ABEO.
- Started 1 new stock position in SSRM.
- Reduced shares in these 7 stocks: , , , MREO, Hookipa Pharma Inc equity, OBIO, Applied Therapeutics.
- Sold out of its positions in DEO, Hookipa Pharma Inc equity, MREO, OBIO, SAND, V.
- Knoll Capital Management was a net buyer of stock by $24M.
- Knoll Capital Management has $218M in assets under management (AUM), dropping by 16.83%.
- Central Index Key (CIK): 0001325083
Tip: Access up to 7 years of quarterly data
Positions held by Knoll Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Knoll Capital Management
Knoll Capital Management holds 33 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Aldeyra Therapeutics (ALDX) | 13.0 | $28M | 5.5M | 5.18 |
|
|
| Biohaven Pharmaceutical Holding | 12.1 | $26M | +160% | 2.3M | 11.29 |
|
| Nuvation Bio Com Cl A (NUVB) | 6.2 | $13M | +46% | 1.5M | 8.96 |
|
| Avadel Pharmaceuticals Sponsored Adr | 5.9 | $13M | 600k | 21.55 |
|
|
| SPDR Gold Trust Gold SHS (GLD) | 5.8 | $13M | 32k | 396.31 |
|
|
| Royal Gold (RGLD) | 5.4 | $12M | +486% | 53k | 222.29 |
|
| Kinross Gold Corp (KGC) | 5.3 | $12M | 410k | 28.16 |
|
|
| Entera Bio SHS (ENTX) | 5.2 | $11M | 5.9M | 1.94 |
|
|
| Meiragtx Holdings (MGTX) | 4.6 | $9.9M | 1.3M | 7.95 |
|
|
| Seabridge Gold (SA) | 4.3 | $9.4M | 317k | 29.59 |
|
|
| Agnico (AEM) | 4.1 | $8.9M | 53k | 169.53 |
|
|
| Ocular Therapeutix (OCUL) | 3.3 | $7.3M | 600k | 12.12 |
|
|
| Centerra Gold (CGAU) | 3.3 | $7.1M | 497k | 14.37 |
|
|
| Ssr Mining (SSRM) | 2.5 | $5.4M | NEW | 245k | 21.92 |
|
| Pan American Silver Corp Can (PAAS) | 2.4 | $5.2M | 100k | 51.81 |
|
|
| Franco-Nevada Corporation (FNV) | 2.4 | $5.2M | 25k | 207.28 |
|
|
| iShares Silver Trust iShares (SLV) | 2.4 | $5.2M | 80k | 64.42 |
|
|
| Elicio Therapeutics (ELTX) | 2.3 | $5.0M | 631k | 7.96 |
|
|
| Altimmune Com New (ALT) | 1.9 | $4.0M | 1.1M | 3.61 |
|
|
| Triple Flag Precious Metals (TFPM) | 0.9 | $2.0M | 59k | 33.22 |
|
|
| Alamos Gold COM CL New (AGI) | 0.9 | $1.9M | 50k | 38.58 |
|
|
| Coeur Mining Com New (CDE) | 0.8 | $1.7M | 96k | 17.83 |
|
|
| New Pac Metals Corp Com Npv Isin Ca64782a1075 Sedol Bmw5909 (NEWP) | 0.8 | $1.7M | 485k | 3.51 |
|
|
| iSHares US Aerospace & Defense Us Aer Def Etf (ITA) | 0.8 | $1.6M | 7.7k | 214.69 |
|
|
| Philip Morris International (PM) | 0.7 | $1.6M | 10k | 160.40 |
|
|
| Wheaton Precious Metals Corp (WPM) | 0.7 | $1.5M | 13k | 117.52 |
|
|
| Abeona Therapeutics Com New (ABEO) | 0.6 | $1.2M | +276% | 236k | 5.27 |
|
| Northrop Grumman Corporation (NOC) | 0.6 | $1.2M | 2.2k | 570.21 |
|
|
| Booz Allen Hamilton HLDG COR Cl A (BAH) | 0.5 | $1.1M | 13k | 84.36 |
|
|
| Dakota Gold Corp (DC) | 0.3 | $698k | 123k | 5.68 |
|
|
| Applied Therapeutics | 0.3 | $605k | -22% | 6.1M | 0.10 |
|
| Cardiol Therapeutics COM Cal A (CRDL) | 0.0 | $95k | 100k | 0.95 |
|
|
| Orgenesis | 0.0 | $7.6k | 51k | 0.15 |
|
Past Filings by Knoll Capital Management
SEC 13F filings are viewable for Knoll Capital Management going back to 2012
- Knoll Capital Management 2025 Q4 filed Feb. 17, 2026
- Knoll Capital Management 2025 Q3 filed Nov. 14, 2025
- Knoll Capital Management 2025 Q2 filed Aug. 14, 2025
- Knoll Capital Management 2025 Q1 filed May 15, 2025
- Knoll Capital Management 2024 Q4 filed Feb. 18, 2025
- Knoll Capital Management 2024 Q3 filed Nov. 14, 2024
- Knoll Capital Management 2024 Q2 filed Aug. 14, 2024
- Knoll Capital Management 2024 Q1 filed May 15, 2024
- Knoll Capital Management 2023 Q4 filed Feb. 14, 2024
- Knoll Capital Management 2023 Q3 filed Nov. 14, 2023
- Knoll Capital Management 2023 Q2 filed Aug. 15, 2023
- Knoll Capital Management 2023 Q1 filed May 15, 2023
- Knoll Capital Management 2022 Q4 filed Feb. 14, 2023
- Knoll Capital Management 2022 Q3 filed Nov. 14, 2022
- Knoll Capital Management 2022 Q2 filed Aug. 15, 2022
- Knoll Capital Management 2022 Q1 filed May 16, 2022